425: Semler Scientific & Strive Merger: Pro Forma Reveals Combined Loss

Semler Scientific files supplemental unaudited pro forma financial information for its all-stock acquisition by Strive, Inc., revealing a significant combined net loss for the nine months ended September 30, 2025.

Summary

• Semler Scientific, Inc. (SMLR) is being acquired by Strive, Inc. (ASST) in an all-stock transaction, as per an Agreement and Plan of Merger dated September 22, 2025.
• This Form 8-K provides supplemental unaudited pro forma combined consolidated financial information for the nine months ended September 30, 2025, and the year ended December 31, 2024.
• Strive is deemed the accounting acquirer, with its existing stockholders expected to hold the greatest voting interest and its management controlling the combined entity's strategic direction.
• Each share of Semler common stock will be converted into the right to receive 21.05 shares of Strive Class A common stock.
• The estimated purchase price consideration for Semler Scientific is approximately $471.7 million, based on 318,743,205 Strive Class A common shares at $1.48 per share.
• The pro forma combined entity shows total assets of $1,401,244 thousand and total liabilities of $160,189 thousand as of September 30, 2025.
• For the nine months ended September 30, 2025, the pro forma combined entity reported a net loss of $(200,145) thousand, with basic and diluted EPS of $(0.43).
• For the year ended December 31, 2024, the pro forma combined entity reported a net income of $9,205 thousand, with basic and diluted EPS of $0.03.

Sentiment

Score: 4

Explanation: The filing presents pro forma financials showing a substantial combined net loss for the most recent period and details numerous significant risks associated with the merger and Bitcoin volatility, outweighing the potential for future benefits.

Positives

• The combined entity for the year ended December 31, 2024, shows a pro forma net income of $9,205 thousand, indicating potential for future profitability.
• The merger aims to achieve strategic and financial benefits, including anticipated cost savings and strategic gains, though these are forward-looking statements.

Negatives

• The pro forma combined entity reported a significant net loss of $(200,145) thousand for the nine months ended September 30, 2025, primarily driven by Strive's historical losses.
• The transaction involves dilution for Strive's existing shareholders due to the issuance of additional Class A common stock.
• Non-recurring acquisition-related expenses of $10.1 million are expected to be incurred.

Risks

• Volatility in Bitcoin and risks related to Semler Scientific's Bitcoin treasury strategy and its healthcare business.
• The possibility that the proposed transaction does not close when expected or at all due to unmet conditions.
• The risk that anticipated benefits, such as cost savings and strategic gains, are not realized as expected, including those related to Bitcoin and digital assets.
• Potential difficulties, time consumption, or increased costs associated with the integration of the two companies.
• Diversion of management's attention from ongoing business operations and opportunities.
• Potential adverse reactions from customers or changes to business or employee relationships resulting from the announcement or completion of the transaction.
• Changes in Strive's or Semler Scientific's share price before closing.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.

Future Outlook

The filing includes forward-looking statements regarding the outlook and expectations of Strive and Semler Scientific with respect to the proposed transaction, including anticipated strategic and financial benefits, the timing of the closing, and the ability to successfully integrate the combined businesses. These statements are subject to inherent risks and uncertainties.

Management Comments

• Strive's designated leadership is expected to control the combined entity's operations post-business combination.
• Strive's existing directors are expected to control the majority of the post-business combination board.

Industry Context

Strive, Inc. operates as a bitcoin treasury asset management firm, generating revenue from investment advisory and bitcoin-related products. Semler Scientific, Inc. is primarily a healthcare business that has also adopted a Bitcoin treasury strategy. The merger combines these entities, creating a company with both healthcare operations and significant exposure to digital asset management, potentially positioning it within the evolving intersection of traditional industries and the digital asset economy.

Comparison to Industry Standards

• Not explicitly detailed in the filing; the document focuses on pro forma financial impacts of the specific merger rather than comparative industry performance benchmarks.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is listed as a risk factor.

Stakeholder Impact

• Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction will cause dilution for existing Strive shareholders.
• There is a risk of potential adverse reactions from Strive's or Semler Scientific's customers or changes to business or employee relationships resulting from the announcement or completion of the proposed transaction.

Next Steps

• Semler Scientific stockholders need to approve the proposed transaction.
• The transaction is subject to the satisfaction or waiver of customary closing conditions.
• Strive will file a Registration Statement (Form S-4) that includes an information statement, proxy statement, and prospectus for the proposed transaction.
• Integration of the two companies' businesses post-closing.

Key Dates

Recommendation

The filing provides supplemental pro forma financial information for a significant merger, revealing a substantial combined net loss for the most recent nine-month period and outlining numerous material risks, particularly concerning Bitcoin volatility and integration challenges. While the merger aims for strategic benefits, the immediate financial outlook presented (pro forma loss) and the extensive risk factors warrant a cautious 'hold' stance until further clarity on integration, actual combined performance, and strategic execution emerges.

Keywords

Merger, Acquisition, Pro Forma Financials, Semler Scientific, Strive Inc, Bitcoin Treasury, Healthcare, SEC Filing, All-Stock Transaction, SMLR, ASST